BridgeMD
New treatment option for Acute Respiratory Distress Syndrome in Children
Official title Assessment of Airway Opening Pressure in Invasively Ventilated Children
ClinicalTrials.gov ID: NCT07262541
What this study is testing
- What it's testing
- Acute respiratory distress syndrome (ARDS) in children is associated with significant morbidity and mortality. Current studies seek to individualize the management of children by defining several phenotypes, based until now mainly on clinical presentation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 17
You may be able to join if
- Minor patients weighing more than 5 kg, hospitalized in the pediatric intensive care unit at Necker-Enfants Malades Hospital and receiving invasive...
- Holders of parental authority must be informed and consent to their child's participation in the study.
- The patient must be passively ventilated to ensure reliable measurements. This means that the patient must not be spontaneously ventilating and must...
You likely can't join if
- Respiratory mechanics preventing interpretation of maneuvers (flow too low and/or resistance too high)
- Patient \< 5 kg
- Refusal by those with parental authority
- Patient not affiliated with social security
- Patient receiving AME (Medical Aid for Life)
- Contraindication or impossibility of performing static respiratory mechanics measurements: pneumothorax or pleural leak, head trauma or threatening...
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.